Literature DB >> 22594862

Polycystic ovary syndrome: a common but often unrecognized condition.

Maureen Shannon1, Yusharn Wang.   

Abstract

Polycystic ovary syndrome (PCOS) affects 5% to 10% of women of reproductive age, with symptoms often presenting during adolescence and young adulthood. It is a condition characterized by (1) hyperandrogenism, (2) oligomenorrhea or amenorrhea, and (3) polycystic ovaries. This syndrome is associated with significant endocrine, metabolic, cardiovascular, reproductive, and psychiatric morbidities. Although the diagnosis of PCOS is based on the presence of at least 2 of the 3 criteria that characterize the condition, the syndrome has a broad spectrum of clinical features that may signal its presence. Evidence suggests that many women with clinical features of PCOS remain undiagnosed, placing them at an increased risk for developing complications associated with the syndrome. This review presents current information about the pathophysiology, clinical features, diagnosis, and recommended treatments for PCOS.
© 2012 by the American College of Nurse-Midwives.

Entities:  

Mesh:

Year:  2012        PMID: 22594862     DOI: 10.1111/j.1542-2011.2012.00161.x

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  12 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

2.  Prevalence of polycystic ovary syndrome in adolescents.

Authors:  Shawna B Christensen; Mary Helen Black; Ning Smith; Mayra M Martinez; Steve J Jacobsen; Amy H Porter; Corinna Koebnick
Journal:  Fertil Steril       Date:  2013-06-05       Impact factor: 7.329

3.  Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches.

Authors:  Uche Anadu Ndefo; Angie Eaton; Monica Robinson Green
Journal:  P T       Date:  2013-06

Review 4.  Association between periodontal disease and polycystic ovary syndrome: a systematic review.

Authors:  S V Kellesarian; V R Malignaggi; T V Kellesarian; A A Al-Kheraif; M M Alwageet; H Malmstrom; G E Romanos; F Javed
Journal:  Int J Impot Res       Date:  2017-03-09       Impact factor: 2.896

Review 5.  N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials.

Authors:  Divyesh Thakker; Amit Raval; Isha Patel; Rama Walia
Journal:  Obstet Gynecol Int       Date:  2015-01-08

6.  Prevalence of Methylenetetrahydrofolate Reductase C677T Polymorphism in women with Polycystic Ovary Syndrome in southeast of Iran.

Authors:  A Naghavi; H Mozdarani; M Garshasbi; M Yaghmaei
Journal:  J Med Life       Date:  2015

Review 7.  Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity.

Authors:  Wendy M Wolf; Rachel A Wattick; Olivia N Kinkade; Melissa D Olfert
Journal:  Int J Environ Res Public Health       Date:  2018-11-20       Impact factor: 3.390

8.  ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole.

Authors:  Qin Lang; Xie Yidong; Zhang Xueguang; Wu Sixian; Xu Wenming; Zuo Tao
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

9.  Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome.

Authors:  Yesim Guvenc; Ahmet Var; Asli Goker; Naci Kemal Kuscu
Journal:  J Int Med Res       Date:  2016-05-25       Impact factor: 1.671

Review 10.  The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis.

Authors:  Marzieh Saei Ghare Naz; Fahimeh Ramezani Tehrani; Hamid Alavi Majd; Fazlollah Ahmadi; Giti Ozgoli; Farzaneh Rashidi Fakari; Vida Ghasemi
Journal:  Int J Reprod Biomed       Date:  2019-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.